Servier founder to take stand in Mediator case

The founder of French drugmaker Servier will appear in court next month to face charges concerning the firm's handling of its withdrawn diabetes drug Mediator, which has been linked to the deaths of up to 2,000 people. Report

Suggested Articles

AZ's tremelimumab has so far suffered a host of clinical failures. But new trial results show the company might be able to use the drug in a new way.

Roche may have just grabbed the first FDA nod for a checkpoint med in previously untreated liver cancer, but Merck is hoping it won’t be far behind.

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.